Skip to Main Content

Author Details

Adam J Lamble
Seattle Children's Hospital, University of Washington
2017
26
11
PMIDPaper TitleJournal TitlePublished Year
37821078INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia.Transplant Cell Ther2024
36634304CREBBP alterations are associated with a poor prognosis in de novo AML.Blood2023
37689393INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia.Transplant Cell Ther2023
35482927Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.Blood Adv2023
37452102Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.Leukemia2023
37442348Introduction to the Reports from the Insights in Pediatric CAR T-cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) Symposium.Transplant Cell Ther2023
36966871Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients.Transplant Cell Ther2023
37027334CD43-positive, EWSR1::FLI1 -rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic Leukemia.J Pediatr Hematol Oncol2023
36763522Plasticity of lineage switch in B-ALL allows for successful rechallenge with CD19-directed immunotherapy.Blood Adv2023
34767461Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.J Clin Oncol2022
35834728Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.Blood Adv2022
35222407Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line.Front Immunol2022
34855461CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.J Clin Oncol2022
34558367Chemotherapy roadmaps in pediatric oncology: A digital electronic medical record integrated solution.J Oncol Pharm Pract2022
32898857Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL.Blood2021
33637765Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.Nat Commun2021
34214968Pediatric Hodgkin Lymphoma, Version 3.2021.J Natl Compr Canc Netw2021
33951732CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.Blood2021
32513686Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.Proc Natl Acad Sci U S A2020
33275678CAR T cells for other pediatric non-B-cell hematologic malignancies.Hematology Am Soc Hematol Educ Program2020
30425048CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.Blood2019
31808843Opportunities for immunotherapy in childhood acute myeloid leukemia.Hematology Am Soc Hematol Educ Program2019
31770440Opportunities for immunotherapy in childhood acute myeloid leukemia.Blood Adv2019
29175391Integrated functional and mass spectrometry-based flow cytometric phenotyping to describe the immune microenvironment in acute myeloid leukemia.J Immunol Methods2018
29951373Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity.Front Oncol2018
28686179When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia.J Clin Med2017
  • 1 - 26 of 26

Recommended Authors

Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Career Start Year 2014
Number of shared co-authors 22
Thai Hoa Tran
Universite de Montreal
Career Start Year 2013
Number of shared co-authors 3
David Wu
University of Washington
Career Start Year 2010
Number of shared co-authors 5
Kara L Davis
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 2
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 6
Emmanuelle Clappier
Saint-Louis Hospital
Career Start Year 2005
Number of shared co-authors 0
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 23
Christopher S Hourigan
and Blood Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 21
Mignon L Loh
University of Washington
Career Start Year 1998
Number of shared co-authors 18
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 3
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 6
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 19
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 3
Meenakshi Devidas
St Jude Children's Research Hospital
Career Start Year 1993
Number of shared co-authors 9
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 4
Bijal Shah
Moffitt Cancer Center
Career Start Year 1992
Number of shared co-authors 3
Stephen P Hunger
Children's Hospital of Philadelphia
Career Start Year 1990
Number of shared co-authors 15
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 2
Michael Dworzak
St. Anna Children's Cancer Research Institute (CCRI)
Career Start Year 1990
Number of shared co-authors 9
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 7
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 11
Sima Jeha
St. Jude Children's Research Hospital
Career Start Year 1988
Number of shared co-authors 4
Robert H Collins
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 23
Richard M Stone
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 11
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 4
Herv?? Dombret
Institut de Recherche Saint-Louis, Universite de Paris
Career Start Year 1984
Number of shared co-authors 1
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Career Start Year 1982
Number of shared co-authors 6

Collaborators

Evan F Lind
Oregon Health & Science University
Co-authored papers 5
Sarah K Tasian
Co-authored papers 4
Soheil Meshinchi
Fred Hutchinson Cancer Research Centre
Co-authored papers 4
Ted Laderas
Oregon Health & Science University
Co-authored papers 3
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 3
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Edward A Kolb
Co-authored papers 3
Todd A Alonzo
Keck School of Medicine, University of Southern California
Co-authored papers 3
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 3
Stephan A Grupp
Co-authored papers 3
Brian J Druker
Oregon Health & Science University
Co-authored papers 2
Alexandra E Kovach
Children's Hospital of Los Angeles
Co-authored papers 2
Yoko Kosaka
Oregon Health & Science University
Co-authored papers 2
Rhonda E Ries
Clinical Research Division, Fred Hutchinson Cancer Research Center
Co-authored papers 2
Richard Aplenc
Children's Hospital of Philadelphia
Co-authored papers 2
Motomi Mori
St Jude Children's Research Hospital.
Co-authored papers 2
Vinodh Pillai
Co-authored papers 2
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Patrick Brown
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 2
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Nicola Long
Oregon Health and Science University
Co-authored papers 2
Alisa Damnernsawad
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
David Tyler Sweeney
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Siob??n B Keel
University of Washington School of Medicine
Co-authored papers 1
Homer C Adams
Janssen Pharmaceutical Companies of Johnson & Johnson
Co-authored papers 1
Dorian LaTocha
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Claudia Rossig
University Children's Hospital Muenster
Co-authored papers 1
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Clare V LeFave
LabConnect LLC
Co-authored papers 1
Release 1.2